Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Conditions: Recurrent Glioblastoma; Recurrent WHO Grade 4 Glioma Interventions: Biological: Bevacizumab; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Other: Electronic Health Record Review; Radiation: Hypofractionated Radiation Therapy; Procedure: Magnetic Resonance Imaging; Biological: Retifanlimab Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academia | Avastin | Brain Tumor | Cancer | Cancer & Oncology | CT Scan | Electronic Health Records (EHR) | Glioma | Information Technology | MRI Scan | Radiation Therapy | Research